ACG and CAG Clinical Guideline: Management of Dyspepsia
Allergan (Ireland) · Takeda (United States) · +9 more institutions
Abstract
We have updated both the American College of Gastroenterology (ACG) and the Canadian Association of Gastroenterology (CAG) guidelines on dyspepsia in a joint ACG/CAG dyspepsia guideline. We suggest that patients ≥60 years of age presenting with dyspepsia are investigated with upper gastrointestinal endoscopy to exclude organic pathology. This is a conditional recommendation and patients at higher risk of malignancy (such as spending their childhood in a high risk gastric cancer country or having a positive family history) could be offered an endoscopy at a younger age. Alarm features should not automatically precipitate endoscopy in younger patients but this should be considered on a case-by-case basis. We…
Citation impact
- FWCI
- 53.36
- Percentile
- 100%
- References
- 191
Authors
6- PMPaul M MoayyediCorresponding
Allergan (Ireland), Takeda (United States), McMaster University Medical Centre, McMaster University, Janssen (Belgium)
- BEBrian E. Lacy
Dartmouth–Hitchcock Medical Center, Allergan (Ireland), Janssen (Belgium), Takeda (United States)
- CNChristopher N. Andrews
University of Calgary, Allergan (Ireland), Takeda (United States), Janssen (Belgium)
- RERobert Enns
Allergan (Ireland), Janssen (Belgium), University of British Columbia, Takeda (United States), St. Paul's Hospital
- CWColin W. Howden
Janssen (Belgium), Takeda (United States), Allergan (Ireland), University of Tennessee Health Science Center
Topics & keywords
- Medicine
- Guideline
- Internal medicine
- Gastroenterology
- Endoscopy
- Proton-pump inhibitor
- Helicobacter pylori
- Cancer
- Good health and well-being